An ophthalmologist warned that wearing contact lenses while sleeping could lead to infection and other complications and ...

The global artificial cornea and corneal implant market size was US$ 381.5 million in 2021. The global artificial cornea and corneal implant market is forecast to grow to US$ 701.4 million by 2030 by ...

Aurion is developing AURN001, a clinical-stage allogeneic cell therapy asset, for corneal edema secondary to corneal ...

Eye care giant Alcon appears to have gained the upper hand in the ongoing power struggle with Aurion Biotech by securing a ...

Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed.

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease ...

Both refractive and corneal astigmatism saw an increase in prevalence in children after the COVID-19 pandemic, with corneal ...

Pakistan: Losartan, a widely used angiotensin II receptor blocker for hypertension, has recently been recognized for its ...

The Asia-Pacific ophthalmic diagnostic devices market was valued at $1,553.80 million in 2019 and is projected to reach $2,182.83 million by 2027, registering a CAGR of 4.3% from 2020 to 2027.

Surrozen (SRZN) announced that the company will focus its Wnt biology expertise and Wnt signal modulation antibody technologies on its ...

The partnership will focus on early myopia detection, portable eye disease screening, and non-invasive diabetes monitoring ...

The 'flexus (arm wing)' that grows on the surface of the eyeball in a wing shape is a disease in which fibrous blood vessels ...